| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 10/17/2006 | US7122196 Compounds and methods for diagnosis of tuberculosis |
| 10/17/2006 | US7122190 Peptide containing amino acids 638 to 673 of the HIV-1LAI gp41 protein, and fragments, analogs and homologs of DP178, inhibitory of human and nonhuman retroviral, especially HIV, transmission to uninfected cells |
| 10/17/2006 | US7122187 Treating autoimmune diseases with humanized anti-CD40L antibody |
| 10/17/2006 | US7122184 Monoclonal antibody for use in prevention of fungal infections |
| 10/17/2006 | US7122183 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of CD30 or CD30L |
| 10/17/2006 | US7122154 Apparatus for testing breath alcohol with discrimination between alveolar and upper respiratory tract alcohol |
| 10/17/2006 | US7122152 Spatiotemporal and geometric optimization of sensor arrays for detecting analytes fluids |
| 10/17/2006 | US7122111 Sample discriminating method |
| 10/17/2006 | US7121519 Silicone mould tool |
| 10/17/2006 | US7121149 Gyratory compactor apparatus and associated devices and methods |
| 10/17/2006 | US7121135 Method and device for determining the permeation of a barrier layer |
| 10/17/2006 | US7121134 Integrated sample cell and filter and system using same |
| 10/17/2006 | CA2419700C Parallel reactor with internal sensing and method of using same |
| 10/17/2006 | CA2359659C Method for quality control of an attenuated varicella live vaccine |
| 10/17/2006 | CA2342141C Method for detection of legionella bacteria employing purified antigen-specific antibodies |
| 10/17/2006 | CA2250090C Method of assaying compressive strength of rock |
| 10/17/2006 | CA2177179C Antagonists to chaperonin 10 |
| 10/17/2006 | CA2150497C Inhibitor and anti-inhibitor monoclonal antibodies specific for horseradish peroxidase |
| 10/13/2006 | CA2522413A1 Markers for sudden death in heart failure |
| 10/12/2006 | WO2006108180A2 Thin film coated microwell arrays and methods of making same |
| 10/12/2006 | WO2006108130A2 Methods to measure immunosuppressive tacrolimus, sirolimus, and cyclosporin a complexes in a blood sample |
| 10/12/2006 | WO2006108095A2 Serum biomarker for disease and methods of using same |
| 10/12/2006 | WO2006108033A2 Recombinant antigens for the detection of coxiella burnetii |
| 10/12/2006 | WO2006107972A2 Permittivity based detection of immunobiological specific bindings in a capacitive cell of coplanar waveguide or microstrip layout using a microwave |
| 10/12/2006 | WO2006107864A1 Screening using polarization anisotropy in fret emissions |
| 10/12/2006 | WO2006107846A2 Biomakers of liver injury |
| 10/12/2006 | WO2006107666A2 Body fluid testing component for analyte detection |
| 10/12/2006 | WO2006107506A2 System and method for performing g protein coupled receptor (gpcr) cell assays using waveguide-grating sensors |
| 10/12/2006 | WO2006107421A2 Preparation of platelet analogs |
| 10/12/2006 | WO2006107371A1 Diagnostic test kits employing an internal calibration system |
| 10/12/2006 | WO2006107370A1 Technique for detecting microorganisms |
| 10/12/2006 | WO2006107331A1 Coated composites of magnetic material and quantum dots |
| 10/12/2006 | WO2006107312A1 Nanosensors |
| 10/12/2006 | WO2006107198A2 Production of unconjugated oligosaccharides by pathogens |
| 10/12/2006 | WO2006107078A1 Method of assessing effectiveness of interferon therapy and kit for assessing the same |
| 10/12/2006 | WO2006107031A1 Method of relative risk for the onset of atopic dermatitis by gene single nucleotide polymorphism analysis |
| 10/12/2006 | WO2006106976A1 Method of assaying antibody against cell membrane surface antigen |
| 10/12/2006 | WO2006106957A1 Monoclonal antibody specifically recognizing modification site after translation of p53 and kit for assaying modification site containing the same |
| 10/12/2006 | WO2006106950A1 Novel anti-heparan sulfate antibody, method for detection of heparan sulfate, and kit for detection of heparan sulfate |
| 10/12/2006 | WO2006106930A1 NUCLEIC ACID PROBE CONTAINING Eu3+ COMPLEX AND METHOD OF ANALYZING NUCLEIC ACID BY USING THE SAME |
| 10/12/2006 | WO2006106912A1 Cancer-associated antigen analog peptide and utilization of the same |
| 10/12/2006 | WO2006106870A1 Method of dispensing in reaction vessel and reaction vessel processing apparatus |
| 10/12/2006 | WO2006106868A1 Method of dispensing nonvolatile liquid in reaction vessel and reaction vessel processing apparatus |
| 10/12/2006 | WO2006106823A1 Method for distinguishing mesenchymal stem cell using molecular marker and use thereof |
| 10/12/2006 | WO2006106752A1 Noninvasive analysis method |
| 10/12/2006 | WO2006106741A1 Bioreaction execution apparatus, method of bioreaction execution, dna chip, information processing unit, method of information processing, program and recording medium |
| 10/12/2006 | WO2006106695A1 Highly sensitive hematological assay and reagent |
| 10/12/2006 | WO2006106678A1 Boron absorption-promoting gene |
| 10/12/2006 | WO2006106661A1 Method for display of determination information of biologically relevant substance |
| 10/12/2006 | WO2006106598A1 Method of evaluating renal disease activity and apparatus therefor |
| 10/12/2006 | WO2006106340A2 Formation of aggregates in enzyme assays |
| 10/12/2006 | WO2006106193A1 Method for obtaining soluble or better expressed variants of a protein of interest |
| 10/12/2006 | WO2006106148A1 Measuring specific activity of glyoxalase i as novel diagnostic/prognostic tool in diabetes pathology and aging processes |
| 10/12/2006 | WO2006106129A2 Polypeptide markers for the diagnosis of prostate cancer |
| 10/12/2006 | WO2006106115A2 Polypeptide marker for diagnosing alzheimer's disease |
| 10/12/2006 | WO2006106004A1 Sensor module, in particular for an air conditioning system |
| 10/12/2006 | WO2006105985A1 Reversible sequential binding assays |
| 10/12/2006 | WO2006105907A1 Neurodegenerative markers for psychiatric conditions |
| 10/12/2006 | WO2006105777A1 Method for obtaining primary-culture tumour cells from tumour tissue, in particular breast carcinoma, primary-culture tumour cells and their use |
| 10/12/2006 | WO2006105665A1 Hydrogel composition for modulation of topical inflammatory response |
| 10/12/2006 | WO2006105653A1 Method and system for identification of antigen |
| 10/12/2006 | WO2006105650A1 Method for cancer detection and monitoring |
| 10/12/2006 | WO2006087637A3 Anti her2/neu antibody |
| 10/12/2006 | WO2006087220A3 Receptacle for the separation of tumor cells |
| 10/12/2006 | WO2006086873A8 Method for determining native wood constituents using visible-light raman spectrometry |
| 10/12/2006 | WO2006086859A3 Method and kit to profile tumours by biomarker analyses including transcriptional factor assays |
| 10/12/2006 | WO2006084299A8 Method for evaluating the allergen sensitivity of an individual |
| 10/12/2006 | WO2006063734A3 Integrin (alpha v beta 1) as target/marker for insulin resistance |
| 10/12/2006 | WO2006059268A3 A method for calibrating a transfer function of a magnetic sensor |
| 10/12/2006 | WO2006056365A3 Method for identification and analysis of measuring values obtained with the aid of an analysis device from a multi-component mixture of materials in variable environmental conditions |
| 10/12/2006 | WO2006052566A3 Gpr41 and modulators thereof for the treatment of insulin-related disorders |
| 10/12/2006 | WO2006050214A3 Method and system for providing online authentication using biometric data |
| 10/12/2006 | WO2006044747A3 P27 ubiquitination assay and methods of use |
| 10/12/2006 | WO2006036212A3 Non-sugar sweeteners for use in test devices |
| 10/12/2006 | WO2006034354A3 Methods of diagnosing and treating vhl associated tumors and sporadic renal cell carcinoma, other vhl sporadic counterpart tumors and non-tumor lesions which co-express epo and the epo receptor |
| 10/12/2006 | WO2006033742A3 Engineered antibody fragment that irreversibly binds an antigen |
| 10/12/2006 | WO2006012507A3 Methods and compositions for risk stratification |
| 10/12/2006 | WO2006006113A9 Microlaboratory for biological fluids analysis using white light illumnation |
| 10/12/2006 | WO2006002382A3 Arrays with cleavable linkers |
| 10/12/2006 | WO2005123774A3 Antibodies to west nile virus polypeptides |
| 10/12/2006 | WO2005116263A3 Methods for rapid forensic analysis of mitochondrial dna |
| 10/12/2006 | WO2005114191A3 Method for a fully automated monoclonal antibody-based extended differential |
| 10/12/2006 | WO2005086611A3 Methods of precise molecular-level determination of ligand-receptor interactions and designing selective drug compounds based on said interactions |
| 10/12/2006 | WO2005069220A3 Method for mapping defects on leather |
| 10/12/2006 | WO2005069004A3 Solid-supported membranes inside porous substrates and their use in biosensors |
| 10/12/2006 | WO2005051320A3 Gcks as modifiers of branching morphogenesis and methods of use |
| 10/12/2006 | WO2005044792A3 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
| 10/12/2006 | WO2005016527A3 Non-pressure based fluid transfer in assay detection systems and related methods |
| 10/12/2006 | WO2005012479A3 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 10/12/2006 | WO2004083389A3 Mbcats as modifiers of the beta-catenin pathway and methods of use |
| 10/12/2006 | WO2003073821A3 Shc PROTEIN-RELATED METHODS AND COMPOSITIONS FOR THE PROGNOSIS OF BREAST, PROSTATE AND OVARIAN CANCER |
| 10/12/2006 | US20060230469 Method and means for determining fitness in plants |
| 10/12/2006 | US20060230466 Gene-targeted animal model of apolipoprotein E4 domain interaction and uses thereof |
| 10/12/2006 | US20060230465 K203 gene and protein |
| 10/12/2006 | US20060229547 Systems and methods for collecting leukocyte-reduced blood components, including plasma that is free or virtually free of cellular blood species |
| 10/12/2006 | US20060229533 Integrated test element |
| 10/12/2006 | US20060229502 Portable medical diagnostic apparatus |
| 10/12/2006 | US20060229470 Calcium receptor-active molecules |
| 10/12/2006 | US20060229444 Can be used for identifying mu3 opiate receptor agonists and antagonists |
| 10/12/2006 | US20060229334 Biphenyl derivatives |